MCRB vs ZBH · rev $1.1M vs P/E 23, rev $8.23B
Seres Therapeutics Inc (MCRB) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
Latest reported ZBH revenue for 2025-12-31 was $8.23B. Net income was $705.1M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
MCRB currently screens at market cap $109.8M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the MCRB and ZBH stock pages for the full models.
Not investment advice.